Analysts' Actions -- FireEye, Kraft, Teva, U.S. Steel and More

RATINGS CHANGES

Acxiom (ACXM) was upgraded to outperform at BMO Capital. $28 price target. Earnings estimates were also increased, given a better growth outlook and higher stock buybacks, BMO said. 

Akorn (AKRX) was downgraded to hold from buy at Deutsche Bank. $33 price target. The company is facing increased competition, Deutsche said. 

Apache (APA) was downgraded to equal-weight at Barclays. $49 price target. The valuation is less attractive, with shares up 45% from the stock's recent low, Barclays said. 

Armstrong World Industries (AWI) was upgraded to overweight by Keybanc. $50 price target. The company is seeing higher demand in North America, Keybanc said. 

Etsy (ETSY) was upgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: ETSY.

FireEye (FEYE) was downgraded to neutral from overweight at JPMorgan. $15 price target. The company is facing a challenging outlook in the security business, JPMorgan said. 

Fitbit (FIT) was initiated with a sell rating at TheStreet Ratings. You can view the full analysis from the report here: FIT.

Twenty-First Century Fox (FOX) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: FOX.

Huntington Ingalls (HII) was downgraded to market perform at Wells Fargo. The valuation is less attractive, as the company is growing slower than its peers, Wells said. 

Houghton Mifflin (HMHC) was downgraded to market perform from outperform at BMO Capital. $17 price target. The company cut guidance and lacks near-term catalysts, BMO said. 

Kraft Heinz (KHC) was upgraded to buy from hold at Deutsche Bank. $103 price target. The company is a market leaders and aggressively cutting costs, Deutsche said. 

Ligand (LGND) was downgraded to sell from hold at Deutsche Bank. The valuation is less attractive, based on a $110 price target, Deutsche said. 

Newfield (NFX) was downgraded to equal-weight from overweight at Barclays. The valuation is less attractive, based on a $44 price target. 

Neenah (NP) was downgraded to neutral from buy at DA Davidson. The valuation is less attractive, based on a $78 price target, Davidson said. 

Teva Pharmaceuticals (TEVA) was downgraded to perform from outperform at Oppenheimer. The company is facing a "toss-up" over the pending decision of Copaxone patents, Oppenheimer said. 

TripAdvisor (TRIP) was downgraded to hold from buy at Deutsche Bank. $63 price target. The company is facing monetization and traffic problems, Deutsche said. 

U.S. Steel (X) was upgraded to hold from underperform at Jefferies. The company is cutting costs and long-term contracts could be repriced higher in the coming quarters, Jefferies said. 

This article was written by a staff member of TheStreet.

More from Stocks

Trump's Tariff Attack Hasn't Brought Pain to These Hot Stocks

Trump's Tariff Attack Hasn't Brought Pain to These Hot Stocks

Biotech Firm Sarepta Surges 40% on Positive Test Results

Biotech Firm Sarepta Surges 40% on Positive Test Results

Dow Dives Nearly 300 Points as Trump Ratchets Up China Trade Fight

Dow Dives Nearly 300 Points as Trump Ratchets Up China Trade Fight

18 Auto Stocks Trump Just Ran Over With His China Tariff Attack

18 Auto Stocks Trump Just Ran Over With His China Tariff Attack

3 Ways for Retirees to Protect Their Portfolios In Volatile Stock Markets

3 Ways for Retirees to Protect Their Portfolios In Volatile Stock Markets